Ann Arbor, Michigan, US and London, UK – NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its csfalzheimers37 multiplex protein assay for Alzheimer’s disease. The assay simultaneously measures 37 human CSF (cerebrospinal fluid) proteins that are believed to have […]
ALAMEDA, Calif.– BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced its majority-owned subsidiary OncoCyte Corporation (OncoCyte) has received a new round of equity financing to fund expansion of its development of novel proprietary diagnostics and therapeutics for cancer in humans. The financing included $4 million […]
VEDBAEK, Denmark — In a multicenter study, Exiqon, in collaboration with LEO Pharma, Bispebjerg Hospital, Gentofte Hospital, Copenhagen University Hospital and University of Copenhagen, has identified promising diagnostic biomarkers of cutaneous T cell lymphoma (CTCL) to distinguish between malignant and benign inflammation – i.e. between CTCL and chronic diseases such as psoriasis, atopic dermatitis and […]
WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases. Based in Uppsala, Sweden, Phadia has approximately 1,500 employees globally and had 2010 […]
Uppsala, Sweden: Phadia, the global leader in allergy and autoimmune related diseases diagnostics, announced the launch of Phadia’s new allergy and autoimmunity testing instruments; Phadia 2500 and Phadia 5000. The new high capacity instruments offers the possibility to combine allergy and autoimmunity testing, which means a throughput 4 to 5 times higher than any other […]
MANSFIELD, Mass. — PrimeraDx today announced the launch of the ICEPlex® system, the only instrument on the market used for simultaneous detection and quantification of disparate target types, such as mRNA, miRNA, SNPs and DNA. “We are excited to have launched the ICEPlex, a quantitative multiplex PCR platform,” stated President and CEO Matthew McManus, MD, […]
SALT LAKE CITY–ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, is pleased to introduce its newest SNP-based microarray technology, the Affymetrix® CytoScan™ HD Array. SNP-based microarrays identify unbalanced chromosomal abnormalities (loss and/or gain of DNA) in patients with unexplained abnormal phenotypes such as […]
UPPSALA, Sweden and COPENHAGEN, Denmark, – Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity testing and monitoring of patients treated with biopharmaceutical drugs. “The addition of BioMonitor’s iLite technology to our portfolio makes us the most complete supplier of solutions for Anti-Drug Antibody (ADA) testing,” says Hans Johansson, Head […]
CAMBRIDGE, Mass. — Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn’s disease. The precise measurement of low abundance cytokines, which was possible using Quanterix’s high sensitivity […]
BALTIMORE and BRESCIA, Italy – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Biodiversity SpA, a private biotechnology company focusing on molecular diagnostics, announced today a regional collaboration to develop and commercialize a comprehensive molecular diagnostic menu for immunocompromised patients on the BD MAX™ System. This portfolio will […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
